Concerns Over Mislabeling in Magic Mushroom Edibles Sold in Portland

A recent study conducted by researchers at Oregon State University analyzed 12 edible products marketed as containing "magic mushrooms" in Portland, Oregon. The investigation revealed that none of the products contained psilocybin, the psychoactive compound associated with these mushrooms. Instead, the researchers found a variety of undisclosed active ingredients, including synthetic psychedelics and other psychoactive substances. Richard van Breemen, a co-author of the study, emphasized the alarming extent of mislabeling, stating, “Rarely do you find 12 products, none of which contain what they're supposed to contain.”

Analysis of ‘magic mushroom’ edibles finds no psilocybin but many undisclosed active ingredients | NewsroomScientific AmericanTechnology Networks

Among the tested products, seven contained undisclosed active ingredients such as caffeine, kava extract, and synthetic psychedelics like mipracetin and 4-hydroxy-diethyltryptamine. These synthetic compounds, which mimic the structure of psilocybin, have not been studied for their effects on humans, raising significant safety concerns. The study's findings are particularly troubling given that the Centers for Disease Control and Prevention (CDC) reported 180 emergency cases related to magic mushroom products in 2024, including 73 hospitalizations and three deaths across 34 states.

Scientific American

The legal landscape surrounding psilocybin varies by state. In Oregon, psilocybin is legal for therapeutic use but must be administered in licensed service centers. Colorado has legalized both medical and recreational use. However, the high costs associated with legal psilocybin services, ranging from $750 to $1,200 per session, may drive consumers towards unregulated products that are often sold in convenience stores. Legal researcher Mason Marks noted that the lack of decriminalization in certain areas may lead individuals to seek out these untested and potentially dangerous alternatives.

Scientific AmericanTechnology NetworksAnalysis of ‘magic mushroom’ edibles finds no psilocybin but many undisclosed active ingredients | Newsroom

Experts have voiced concerns regarding the implications of these findings. Lori Bruce, a bioethicist at Yale University, highlighted that the mislabeling of products can lead to increased harm as more individuals experiment with psychedelics outside of controlled environments. She stated, “As usage rates increase across the U.S., harms from retail products are also likely to increase.” The study underscores the need for better regulation and testing of psychedelic products to ensure consumer safety.

Scientific American

The researchers advocate for improved analytical methods to detect synthetic analogues and mislabeling in consumer products. Van Breemen emphasized the importance of collaboration among academia, public health, and industry to develop effective detection techniques. He noted, “Advances in analytical chemistry are needed to expose misbranding and support law enforcement and regulatory agencies.”

Analysis of ‘magic mushroom’ edibles finds no psilocybin but many undisclosed active ingredients | Newsroom

• “We found no evidence of mushroom compounds of any kind, coming from any species,” — Richard van Breemen, Co-author of the Study

Scientific American

• “The mislabeling highlighted in this [study] causes harms,” — Lori Bruce, Bioethicist at Yale University

Scientific American

• “We don’t know what harm they might cause,” — Richard van Breemen, Co-author of the Study

Scientific American

The findings of this study raise critical questions about the safety and regulation of magic mushroom edibles, emphasizing the need for increased scrutiny and consumer awareness in the evolving landscape of psychedelic substances.

Technology Networks